Daiichi Sankyo is a leader in the Japanese pharmaceuticals business. The company manufactures prescription drugs, including treatments for cardiovascular, bone and joint, autoimmune, metabolic, and infectious diseases. Top products include Olmetec for hypertension, Loxonin for inflammation, Efient for patients with acute coronary syndrome, and edoxaban to help prevent venous thromboembolism. Daiichi Sankyo also makes over-the-counter (OTC) and generic drugs through subsidiaries including Daiichi Sankyo Healthcare. Daiichi Sankyo's products are sold through medical representatives and distributors located around the globe.